Centarix Biotech

Company Overview

Snapshot

Founded in May 2017 by Shimon Meshi, Itzhak Dershowitz, and Noam Maoz, Centarix Biotech operates with 11–50 employees. The company has raised $30,000,000 across one funding round, reaching a Series A stage. Centarix Biotech is actively developing gene therapies and advanced diagnostics to address the aging process.

Business overview

Centarix Biotech is a cutting-edge health tech and life sciences company focused on extending health span by targeting the fundamental mechanisms of aging. The company develops gene therapies designed to slow and reverse aging at a molecular level, alongside creating accurate and comprehensive aging diagnostics. These diagnostics and data analysis form the foundation of its longevity clinics, enabling precise diagnosis and prescription of effective longevity treatments for clients globally. Centarix Biotech operates in the biotechnology, drug discovery, and wellness sectors, serving B2C, B2B2C, and B2B markets across North America, South America, Europe, and Asia.

Company Intelligence Q&A

What is Centarix Biotech's primary focus?

Centarix Biotech is focused on increasing health and performance by slowing down and reversing the aging process through gene therapy and advanced diagnostics.

When was Centarix Biotech founded?

Centarix Biotech was founded in May 2017.

Who are the founders of Centarix Biotech?

The founders of Centarix Biotech are Shimon Meshi, Itzhak Dershowitz, and Noam Maoz.

What is Centarix Biotech's current employee count?

Centarix Biotech has 11–50 employees.

What is Centarix Biotech's total funding to date?

Centarix Biotech has raised a total of $30,000,000 in a Series A funding round. This funding was secured in a single round.